BURROWS SCOTT L

PrivateCIK: 1853327
Location

WALTHAM, MA

BURROWS SCOTT L (Chief Financial Officer) sold 7.1% of their position (7.50K shares) of SPYRE THERAPEUTICS, INC. on the open market

Open‑market sale worth $532.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales
InsiderBURROWS SCOTT LCIK 1853327
IssuerSPYRE THERAPEUTICS, INC.CIK 1636282
Officer· Chief Financial Officer
Since Mar 2026
-7.50K
Net shares
Net seller
$532.9K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+7.50K

Price / share

$14.50

Trade value

$108.75K

% of position

7.7%
6/1/2026
97.99K105.49K

Common Stock

Direct
S · Sale

Shares

1.80K

Price / share

$69.75

Trade value

$125.62K

% of position

1.7%
6/1/2026
105.49K103.69K

Common Stock

Direct
S · Sale

Shares

2.60K

Price / share

$70.77

Trade value

$183.93K

% of position

2.5%
6/1/2026
103.69K101.09K

Common Stock

Direct
S · Sale

Shares

3.10K

Price / share

$72.06

Trade value

$223.39K

% of position

3.1%
6/1/2026
101.09K97.99K
Total

Net shares

+0.00

Net value

-$424.19K

Derivative Transactions1

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

7.50K shares

Shares

7.50K

Strike price

14.50

Held after

374.86K

Exercisable

6/1/2026
BURROWS SCOTT L — Insider Transaction (Form 4) Filed Jun 4, 2026 | Finecho